These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 15084142)

  • 1. Cardiovascular safety of beta(2)-adrenoceptor agonist use in patients with obstructive airway disease: a systematic review.
    Salpeter SR
    Drugs Aging; 2004; 21(6):405-14. PubMed ID: 15084142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular effects of beta-agonists in patients with asthma and COPD: a meta-analysis.
    Salpeter SR; Ormiston TM; Salpeter EE
    Chest; 2004 Jun; 125(6):2309-21. PubMed ID: 15189956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhaled beta2-adrenoceptor agonists: cardiovascular safety in patients with obstructive lung disease.
    Cazzola M; Matera MG; Donner CF
    Drugs; 2005; 65(12):1595-610. PubMed ID: 16060696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A benefit-risk assessment of inhaled long-acting beta2-agonists in the management of obstructive pulmonary disease.
    Sovani MP; Whale CI; Tattersfield AE
    Drug Saf; 2004; 27(10):689-715. PubMed ID: 15350154
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential adverse effects of bronchodilators in the treatment of airways obstruction in older people: recommendations for prescribing.
    Gupta P; O'Mahony MS
    Drugs Aging; 2008; 25(5):415-43. PubMed ID: 18447405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Corticosteroids and adrenoceptor agonists: the compliments for combination therapy in chronic airways diseases.
    Sin DD; Man SF
    Eur J Pharmacol; 2006 Mar; 533(1-3):28-35. PubMed ID: 16457807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beta-adrenoceptor responses of the airways: for better or worse?
    Broadley KJ
    Eur J Pharmacol; 2006 Mar; 533(1-3):15-27. PubMed ID: 16469310
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Agonists of beta2 adrenergic receptor in the therapy of obstructive diseases].
    Płusa T
    Pol Merkur Lekarski; 2010 Jan; 28(163):8-12. PubMed ID: 20369715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of inhaled corticosteroid and long-acting beta-agonist combination therapy on outcomes in COPD.
    Hanania NA
    Pulm Pharmacol Ther; 2008; 21(3):540-50. PubMed ID: 18280761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overcoming gaps in the management of asthma in older patients: new insights.
    Barua P; O'Mahony MS
    Drugs Aging; 2005; 22(12):1029-59. PubMed ID: 16363886
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological modulation of beta-adrenoceptor function in patients with coexisting chronic obstructive pulmonary disease and chronic heart failure.
    Matera MG; Martuscelli E; Cazzola M
    Pulm Pharmacol Ther; 2010 Feb; 23(1):1-8. PubMed ID: 19833222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiovascular risks associated with beta-agonist therapy.
    Murray JJ
    Chest; 2005 Jun; 127(6):2283-5. PubMed ID: 15947352
    [No Abstract]   [Full Text] [Related]  

  • 13. Beta-agonists, beta-blockers and obstructive airway disease.
    Madalena Esteves M
    Eur Ann Allergy Clin Immunol; 2005 Dec; 37(10):375-9. PubMed ID: 16528900
    [No Abstract]   [Full Text] [Related]  

  • 14. Safety, tolerability and efficacy of indacaterol, a novel once-daily beta(2)-agonist, in patients with COPD: a 28-day randomised, placebo controlled clinical trial.
    Beier J; Chanez P; Martinot JB; Schreurs AJ; Tkácová R; Bao W; Jack D; Higgins M
    Pulm Pharmacol Ther; 2007; 20(6):740-9. PubMed ID: 17088091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk versus benefit considerations for the beta(2)-agonists.
    Kelly HW
    Pharmacotherapy; 2006 Sep; 26(9 Pt 2):164S-74S. PubMed ID: 16945063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardioselective beta-blockers in patients with reactive airway disease: a meta-analysis.
    Salpeter SR; Ormiston TM; Salpeter EE
    Ann Intern Med; 2002 Nov; 137(9):715-25. PubMed ID: 12416945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular events in patients with COPD: TORCH study results.
    Calverley PM; Anderson JA; Celli B; Ferguson GT; Jenkins C; Jones PW; Crim C; Willits LR; Yates JC; Vestbo J;
    Thorax; 2010 Aug; 65(8):719-25. PubMed ID: 20685748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-acting beta2 agonists in the management of stable chronic obstructive pulmonary disease.
    Cazzola M; Donner CF
    Drugs; 2000 Aug; 60(2):307-20. PubMed ID: 10983735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The risk of myocardial infarction associated with inhaled beta-adrenoceptor agonists.
    Au DH; Lemaitre RN; Curtis JR; Smith NL; Psaty BM
    Am J Respir Crit Care Med; 2000 Mar; 161(3 Pt 1):827-30. PubMed ID: 10712329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ultra-long-acting beta2-adrenoceptor agonists: an emerging therapeutic option for asthma and COPD?
    Matera MG; Cazzola M
    Drugs; 2007; 67(4):503-15. PubMed ID: 17352511
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.